Fentanyl Transdermal Patch and Nalbuphine: Interaction Details

Brand names
Fentanyl Transdermal Patch
DuragesicAbstralSubsys +3 more
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Fentanyl Transdermal Patch and Nalbuphine interaction:

Share

Share this interaction

Nalbuphine

We don't have a drug information page for Nalbuphine yet. Have a question about Nalbuphine? Ask a pharmacist, free →

Fentanyl Transdermal Patch

Brand names
  • Duragesic
  • Abstral
  • Subsys
  • Ionsys
  • Actiq
  • Fentora

What Happens When You Take Fentanyl Transdermal Patch With Nalbuphine

What can happen when they are taken together (rated Major)

Reduced analgesic effect or precipitation of withdrawal symptoms, and an increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Fentanyl should not be used together with a mixed / or a partial agonist opioid analgesic, because the combination may lessen the analgesic effect of fentanyl and/or may trigger withdrawal symptoms. The combination may also raise the risk of serotonin syndrome, which can be fatal.

Its manifestations may include mental status changes (eg, agitation, hallucinations, coma), autonomic instability (eg, , labile blood pressure, hyperthermia), neuromuscular abnormalities (eg, hyperreflexia, incoordination, rigidity), and/or symptoms (eg, nausea, vomiting, diarrhea). When use of both agents is justified, the patient should be monitored closely, especially at the start of therapy and whenever the dose is changed.

Symptoms typically appear within several hours to a few days after the drugs are combined, though they can emerge later. If serotonin syndrome is suspected, fentanyl should be discontinued.4321

The Fentanyl Transdermal Patch and Nalbuphine Interaction, Explained

Nalbuphine and the fentanyl patch (Duragesic) are both pain medicines, but they work a bit differently. Nalbuphine partly blocks the same receptors that fentanyl turns on. Taken together, your fentanyl may not control pain as well, and in some people it can bring on withdrawal symptoms like sweating, restlessness, or achiness.

There is also a possible, theoretical risk of , a rare but serious reaction. Warning signs include agitation, fast heartbeat, fever, stiff muscles, or vomiting and diarrhea. Please don't change anything on your own. Talk with your pharmacist or doctor, who can review your plan and watch you closely if both are needed.

Mechanism: Nalbuphine is a mixed kappa /mu (partial). It may competitively displace fentanyl at the mu receptor in -tolerant patients, reducing analgesia and possibly precipitating withdrawal. with fentanyl may raise risk.

  • Direction: ; reduced fentanyl or withdrawal, plus toxicity risk.
  • Onset: unspecified; serotonin syndrome typically within hours to days, but may occur later.
  • Evidence: theoretical; severity rated major.
  • Management: avoid . If warranted, observe closely, especially at initiation and dose changes. Discontinue fentanyl if serotonin syndrome is suspected.

See the 4 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Fentanyl Transdermal Patch and Nalbuphine Interact

The likely mechanism

receptor ;

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Fentanyl Transdermal Patch and Nalbuphine Interaction

The usual approach is to avoid using these two together. If your care team decides both are needed, they may monitor you more closely, especially when starting or changing a dose, and your doses may need to be individualized.

  • Do not stop or change either medicine on your own. Check with your pharmacist or prescriber first.
  • Tell them if pain control worsens or you notice withdrawal-type symptoms.
  • Seek care right away for agitation, hallucinations, fast heartbeat, fever, muscle stiffness, or vomiting and diarrhea.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Fentanyl Transdermal Patch or Nalbuphine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Fentanyl Transdermal Patch and Nalbuphine: Common Questions

How serious is the Fentanyl Transdermal Patch and Nalbuphine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Fentanyl Transdermal Patch and Nalbuphine interaction managed?

The usual approach is to avoid using these two together. If your care team decides both are needed, they may monitor you more closely, especially when starting or changing a dose, and your doses may need to be individualized. Do not stop or change either medicine on your own. Check with your pharmacist or prescriber first. Tell them if pain control worsens or you notice withdrawal-type symptoms. S… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Fentanyl Transdermal Patch and Nalbuphine Interaction

Ask in your own words about taking Fentanyl Transdermal Patch and Nalbuphine together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (4)

  1. Product Information: DURAGESIC(R) transdermal system, fentanyl transdermal system. Janssen Pharmaceuticals Inc (per manufacturer), Titusville, NJ, 2018. DailyMed
  2. Product Information: ACTIQ(R) oral transmucosal lozenge, fentanyl citrate oral transmucosal lozenge. Teva Pharmaceuticals USA, Inc. (per FDA), Parsippany, NJ, 2023. DailyMed
  3. Product Information: Fentanyl citrate intravenous, intramuscular injection, fentanyl citrate intravenous, intramuscular injection. Hospira Inc (per FDA), Lake Forest, IL, 2023. DailyMed
  4. Product Information: FENTORA(R) buccal tablets, fentanyl citrate buccal tablets. Teva Pharmaceuticals USA Inc (per FDA), Parsippany, NJ, 2023.
Was this write-up helpful?

Other Serious Interactions of Fentanyl Transdermal Patch and Nalbuphine

Also serious with Nalbuphine

Also serious with Fentanyl Transdermal Patch

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Nalbuphine

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.